D a t a s o u r c e s
Studies were identified by using MEDLINE (1966 to April 1995) and bibliographies of relevant studies and by contacting experts.
S t u d y s e l e c t i o n
Studies were selected if they were randomized controlled trials with ≥ 6 months of follow-up of counseling or educational interventions with or without medications aimed at controlling ≥ 1 cardiovascular risk factor (blood pressure, smoking, total blood cholesterol level, physical activity, and diet) in persons ≥ 40 years of age who show no evidence of cardiovascular disease.
D a t a e x t r a c t i o n
Data were extracted independently by 2 reviewers on study design aspects, patient baseline characteristics, and follow-up. Outcomes were changes in blood pressure and total blood cholesterol level, smoking, all-cause mortality, and CAD mortality.
M a i n r e s u l t s 18 trials (140 245 patients) were included. Heterogeneity existed among the trials for all outcomes except CAD mortality (2 trials focused on hypertensive patients). Blood pressure, total blood cholesterol level, and smoking prevalence decreased more in patients who received risk factor modification than in patients who received no intervention or usual care (Table) . 10 trials included clinical outcomes. All-cause and CAD mortality were not reduced by risk factor modification (Table) .
C o n c l u s i o n
In persons who show no evidence of established cardiovascular disease, multiple risk factor interventions consisting of either counseling or educational interventions modestly reduce blood pressure, total blood cholesterol level, and smoking prevalence but not all-cause or coronary artery disease mortality. 
Sources of funding: NHS

C o m m e n t a r y
Ebrahim and Davey Smith conclude that counseling or education to reduce cardiovascular risk factors fails to reduce all-cause mortality or mortality from CAD. This conclusion is not surprising because patients included in these studies were from the general population and at average risk for CAD, and the trials had a median follow-up of 3 years. The benefits of risk factor reduction may develop after many years. All risk factors are not created equal. The potential benefits of behavioral approaches to reduce tobacco use in average-risk patients are greater than those of counseling to alter diet or increase exercise. The cost-effectiveness of smoking cessation programs is < $1000 per life-year saved (1) . It is also important to emphasize the potential benefit of adjunctive pharmacologic therapy to counseling or education. The addition of a 9-week course of sustained-release bupropion, with or without nicotine replacement therapy, to a brief physician advice and counseling program may produce 1-year abstinence rates > 30% (2 
